NRX Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRXP and other ETFs, options, and stocks.About NRXP
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
CEOJonathan C. Javitt
CEOJonathan C. Javitt
Employees—
Employees—
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2017
Founded2017
Employees—
Employees—
NRXP Key Statistics
Market cap61.05M
Market cap61.05M
Price-Earnings ratio-1.62
Price-Earnings ratio-1.62
Dividend yield—
Dividend yield—
Average volume240.45K
Average volume240.45K
High today$3.25
High today$3.25
Low today$3.10
Low today$3.10
Open price$3.25
Open price$3.25
Volume187.38K
Volume187.38K
52 Week high$6.01
52 Week high$6.01
52 Week low$1.10
52 Week low$1.10
People also own
Based on the portfolios of people who own NRXP. This list is generated using Robinhood data, and it’s not a recommendation.